Results 261 to 270 of about 76,979 (321)

Invasive Pneumococcal Disease Epidemiology and Serotype Replacement After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Ontario, Canada, 2007-2022. [PDF]

Open Forum Infect Dis
Grewal R, Hillier K, Deeks SL, Yeung AH, Wilson SE, Wijayasri S, Harris TM, Buchan SA.   +7 more
europepmc   +1 more source

Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine Among US Children with Underlying Medical Conditions. [PDF]

Infect Dis Ther
Rozenbaum MH, Chilson E, Farkouh R, Huang L, Cane A, Arguedas A, Tort MJ, Snow V, Averin A, Weycker D, Hariharan D, Atwood M.   +11 more
europepmc   +1 more source

Indirect impact of childhood 13-valent pneumococcal conjugate vaccine (PCV13) in Canadian older adults: a Canadian Immunization Research Network (CIRN) retrospective observational study. [PDF]

Thorax
Nasreen S, Wang J, Marra F, Kwong JC, McGeer A, Sadarangani M, Wilson SE, Fadel SA.   +7 more
europepmc   +1 more source

Mortality of Invasive Pneumococcal Disease following Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Greenland. [PDF]

Vaccines (Basel)
Alexandrova Nikolova K, Andersson M, Slotved HC, Koch A.   +3 more
europepmc   +1 more source

Correction to: Pivotal Phase 3 Randomized Clinical Trial of the Safety, Tolerability, and Immunogenicity of 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥18 Years. [PDF]

Clin Infect Dis
europepmc   +1 more source

Immunogenicity, Immunological Memory and Monitoring of Disease Activity Following an Anamnestic Immunization With the 13-Valent Pneumococcal Conjugate Vaccine in Children With Idiopathic Nephrotic Syndrome. [PDF]

J Pediatric Infect Dis Soc
Kitsou K, Askiti V, Tzanoudaki M, Mitsioni A, Papadatou I, Liatsis E, Kanaka-Gantenbein C, Magiorkinis G, Spoulou V.   +8 more
europepmc   +1 more source

A Phase Three Study of the Safety and Immunogenicity of a Four-dose Series of 20-Valent Pneumococcal Conjugate Vaccine in Healthy Infants. [PDF]

Pediatr Infect Dis J
Senders S, Klein NP, Tamimi N, Thompson A, Baugher G, Trammel J, Peng Y, Giardina P, Scully IL, Pride M, Center KJ, Gruber WC, Scott DA, Watson W.   +13 more
europepmc   +1 more source

Effect of Pneumococcal Conjugate Vaccine on Pneumonia Incidence Rates among Children 2-59 Months of Age, Mongolia, 2015-2021. [PDF]

Emerg Infect Dis
von Mollendorf C, Ulziibayar M, Nguyen CD, Batsaikhan P, Suuri B, Luvsantseren D, Narangerel D, de Campo J, de Campo M, Tsolmon B, Demberelsuren S, Dunne EM, Satzke C, Mungun T, Mulholland EK.   +14 more
europepmc   +1 more source